Search

everythinglearnresearchcommunity

for

Search:↓

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Long COVID is complex, affects many survivors, and needs more research for effective treatments.

COVID-19 can cause skin problems.

Anti-androgens might help reduce COVID-19 severity in men.

People with hypohidrotic ectodermal dysplasia are more likely to experience long-term fatigue and hair loss after COVID-19.

Age, health conditions, race, and gender affect COVID-19 risk.

Cholesterol affects coronavirus spread and could be a target for treatment.

New therapies are being developed that target integrin pathways to treat various diseases.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

MIS-A is a severe complication after COVID-19, mostly in young black males, needing more research and awareness.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

COVID-19 can increase the risk of hair loss, especially in people over 40.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Eating plant-based anti-inflammatories and antioxidants may help manage long-term COVID-19 health issues.

Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.

Natural products might help treat COVID-19, but current drugs like hydroxychloroquine haven't worked.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Drug repurposing speeds up development, cuts costs, and uses known safe drugs, but faces challenges like regulations and patents.

A COVID-19 infected patient with chronic kidney disease experienced worsened kidney function, hair loss, and unexpected wart clearance.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

The method effectively predicts new drug uses, including potential COVID-19 treatments.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

A new treatment using gold nanoclusters can safely reduce unwanted hair growth.

Enhancing antioxidant responses can improve treatments for various diseases.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

COVID-19 treatments and vaccines face challenges due to genetic differences in people and the virus.

Cepharanthine has many medicinal uses but needs improvement for better effectiveness.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.